Abstract
Introduction

Fibrotic disorders, including systemic sclerosis (SSc) and idiopathic pulmonary fibrosis (IPF), are characterized by excessive deposition of extracellular matrix (ECM) components such as collagen and fibronectin (FN)
. Fibrosis is the result of abnormal ECM remodelling which occurs due to an imbalance of ECM deposition and degradation [3, 4] . Activated fibroblasts are a primary source of ECM in fibrotic tissues [5] . Although numerous studies have explored the fibrotic process in different tissues, the exact pathogenic mechanism responsible for fibrosis in SSc and IPF has not been elucidated.
Caveolin-1 (Cav-1) is a 22-kD membrane protein essential for the formation of flask-shaped 50-100 nm membrane invaginations
termed caveolae [6] . Since caveolae have a distinctive composition of lipids, including cholesterol and sphingolipids, they serve as a platform for processes such as trafficking, endocytosis and signalling [7] [8] [9] . Cav-1 was recently implicated in fibrosis. Kasper et al. first reported abnormal Cav-1 expression in type I pneumocytes during lung fibrogenesis [10] . Tourkina [11] . In addition, markedly decreased expression of Cav-1 in primary fibroblasts, lung and skin tissues of patients with SSc and IPF was reported [12, 13] . Several [14] [15] [16] . Further confirmation for the role of Cav-1 in fibrosis was demonstrated in Cav-1 knockout mice, which exhibit a wide range of fibrosis-like lung abnormalities including thickening of lung alveolar septa and presence of hypertrophic type II pneumocytes [17, 18] . [19] . [20] [21] [22] [23] . are the most abundant and conserved IGFBPs, respectively. They are secreted proteins which can also translocate to the nucleus via a nuclear localization sequence [24, 25] . Nuclear IGFBP-3 and -5 are believed to be derived from the corresponding secreted proteins, and their uptake by cells likely occurs through putative receptors which have not yet been identified [26] .
et al. subsequently identified a role for Cav-1 in regulating collagen expression in lung fibroblasts
studies have shown that Cav-1 regulates a variety of signalling molecules and receptors, including Smad/transforming growth factor (TGF)-␤ receptor, Akt, extracellular signal-regulated kinase 1/2 (ERK1/2) and mitogen-activated protein kinase (MAPK)/ERK (MEK), which interact with Cav-1 scaffolding domain (CSD) corresponding to amino acids 82-101 of Cav-1
Insulin-like growth factor binding proteins (IGFBPs) were originally reported as regulators of insulin-like growth factor (IGF)-I function
Secreted IGFBPs serve as carriers of IGF-I and modulate IGF-I actions, either potentiating or inhibiting them. Several studies have reported that IGFBPs also exert IGF-I-independent effects
We have previously reported that IGFBP-5 is significantly increased in dermal and pulmonary fibroblasts and tissues of patients with SSc and IPF [27, 28] . IGFBP-5 binds ECM components and its deposition in the extracellular milieu is increased in fibrotic cells and tissues [28] . Notably, IGFBP-5 induces the production of ECM components in vitro by IGF-I independent mechanisms [29, 30] and triggers a fibrotic phenotype in vivo [31] that includes induction of ECM production, myofibroblastic transformation and infiltration of mononuclear cells [29, 32] . Furthermore, IGFBP-5 triggers significant fibrosis in human skin using an ex vivo organ culture model [33] . [27] .
In this study, we investigated the internalization and nuclear translocation of IGFBP-5 in association with Cav-1 in primary lung fibroblasts. Our findings demonstrate that IGFBP-5 binds Cav-1, is internalized via Cav-1-mediated pathways, and subsequently translocates to the nucleus as vesicular-like aggregates that lack a membrane and contain Cav-1. Further, IGFBP-5 is increased in the ECM
Materials and methods
Primary fibroblast culture
Adenovirus construct preparation
Adenovirus constructs were generated as previously reported [28] . Briefly, the full-length cDNAs of human 
Purification of caveolae-enriched membrane fractions
Caveolae-enriched membrane fractions were purified as previously described [34] . 
Western blot analysis
Supernatants, cellular lysates and ECM were obtained from cultured fibroblasts as previously described [28] 
Preparation of fibroblast nuclear and cytoplasmic extracts
Nuclear and cytoplasmic fractions were extracted from cultured human and mouse fibroblasts as previously described [36] . 
IGFBP-5 degradation assay
Disruption of caveolar structure
To disrupt caveolae, methyl-␤-cyclodextrin (M␤CD: Sigma-Aldrich) was used. Briefly, primary lung fibroblasts were incubated in the presence or absence of 10 mM M␤CD for 1 hr at 37ЊC under serum-free conditions. 
Silencing of Cav-1
Lysates were immunoprecipitated with anti-Cav-1 antibody or rabbit IgG (IgG). Co-precipitation of IGFBP-5 was examined by immunoblotting (IB). Cav-1 and rabbit immunoglobulins are shown as controls. Left panel: NT cells. Right panel: cAd-or Ad5-infected cells.
Caveolin-1 translocates to the nucleus in IGFBP-5-expressing fibroblasts
Since IGFBP-5 is a secreted protein that translocates to the nucleus to exert its transcription-regulatory activity [20] , we speculated that the interaction of Cav-1 with IGFBP-5 on the cell membrane may result in nuclear trafficking of both proteins. We therefore examined Cav-1 levels in nuclear extracts of IGFBP-5-expressing primary fibroblasts. As shown in Figure 2A, Fig. 2A, right part) [37] , we extended our confirmation of Cav-1 and IGFBP-5 co-localization and nuclear translocation using electron microscopy (Fig. 3) . Vesicle-like structures were detected in the cytoplasm and the nucleus of IGFBP-5 expressing fibroblasts (Fig. 3B-F) but were not present in control fibroblasts (Fig. 3A) . Extensive analysis of these vesicle-like structures revealed the absence of a membrane, suggesting that they consisted of protein aggregates. Upon entry in these nucleus, aggregates of various sizes seemed to fuse and form larger and denser aggregates (Fig. 3C-F) . Using immuno-electron microscopy, we confirmed that both Cav-1 and IGFBP-5 are components of these aggregates in IGFBP-5-expressing fibroblasts (Fig. 3G-L Figure 6A , 
(G-L) Ad5-infected human fibroblasts subjected to immuno-TEM. (H) and (I) represent magnified regions of the nucleus shown in (G). (J-L) show higher magnification of gold particles detected in inclusions and protein aggregates in the nucleus. Ten nanometre gold particles (white arrow) identify Cav-1, and 5 nm gold particles (representative white arrowheads) identify IGFBP-5. Size of bars is indicated.
Caveolin-1 regulates nuclear compartmentalization of IGFBP-5
Increased levels of extracellular IGFBP-5 and decreased intracellular levels in Cav-1 -/-mouse fibroblasts led us to speculate that
Cav-1 might regulate the internalization of secreted IGFBP-5. To determine if secreted IGFBP-5 requires Cav-1 for internalization, 3ϫ FLAG-tagged IGFBP-5 (FLBP-5) secreted by WT fibroblasts was added to WT and Cav-1 -/-fibroblasts. After 15 min., IGFBP-5 levels corresponding to internalized protein were detected in cellular lysates using anti-FLAG antibody. As shown in
following the addition of FLAG-tagged IGFBP-5 (Fig. 6B, C). The decrease in IGFBP-5 uptake reached significance at 30 min. (Fig. 6B and C, right panels). Depletion of cholesterol and silencing of Cav-1 both reduced cellular uptake of IGFBP-5, suggesting that both Cav-1 and intact caveolae contribute to the internalization of IGFBP-5.
IGFBP-5 trafficking can be restored by restitution of Cav-1 function
IGFBP-5 protects ECM components from degradation
We have previously demonstrated increased expression, secretion, and ECM deposition of IGFBP-5 in primary fibroblasts from patients with SSc and IPF [27, 28] . We have also reported that IGFBP-5 induces production of collagen and FN and binds these ECM components [28] . In addition, we and others have reported reduced levels of Cav-1 in primary fibroblasts from patients with SSc and IPF [12, 13] . [20, 24, 25] . Since inhibition of protein secretion abolished IGFBP nuclear localization, it was deduced that nuclear IGFBP-3 and -5 are derived from the secreted proteins [20, 41] . We have also reported that nuclear translocation of IGFBP-5 occurs in a time-dependent, MAPK-dependent and IGF-I independent manner [30] . The internalization and nuclear transport of IGFBP-3, a protein with significant homology to IGFBP-5 containing a nuclear localization sequence, is documented in a variety of cells and includes caveolin-and clathrin-dependent pathways [24, 25, 41] [12, 13] . Furthermore, we have reported increased IGFBP-5 in fibroblasts, skin and lung tissues from patients with these same diseases [27, 28] [27, 28] . Secreted IGFBP-5 induces production of collagen and FN [29] and accumulates in the ECM due to inefficient internalization in fibrotic cells that have reduced Cav-1 levels [12, 13] . Extracellular IGFBP-5 binds components of the ECM and protects them from proteolytic degradation, thus perpetuating the accumulation of ECM components and supporting the fibrotic phenotype. In addition, we recently reported that IGFBP-5 has a chemoattractant activity and promotes the migration of mononuclear cells into lung tissues [29, 30, 32] and the transition of fibroblasts and epithelial cells to a myofibroblastic phenotype [29] [30] [31] [32] [10] . In addition, pulmonary artery smooth muscle cells from patients with idiopathic pulmonary arterial hypertension have increased Cav-1 levels which contributes to pulmonary artery smooth muscle cell proliferation and hypertrophy of the pulmonary vascular wall [51] , an effect opposite the phenotype described in Cav-1 null mice [17, 18] 
